{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:32:40Z","timestamp":1793424760471,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571988"],"award-info":[{"award-number":["82571988"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Development Funds of Peking University People\u2019s Hospital","award":["RDGS2024-04"],"award-info":[{"award-number":["RDGS2024-04"]}],"id":[{"id":"https:\/\/ror.org\/035adwg89","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10067-026-08418-y","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:21:47Z","timestamp":1789489307000},"page":"6621-6632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR56 and CD319 identify distinct cytotoxic-associated DP and DN T-cell subsets in early systemic lupus erythematosus"],"prefix":"10.1007","volume":"45","author":[{"given":"Xiaochen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihui","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayibaota","family":"Bahabayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-5626","authenticated-orcid":false,"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"8418_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.semarthrit.2008.10.007","volume":"39","author":"GJ Pons-Estel","year":"2010","unstructured":"Pons-Estel GJ, Alarc\u00f3n GS, Scofield L et al (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39:257\u2013268. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.10.007","journal-title":"Semin Arthritis Rheum"},{"key":"8418_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X (2025) Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther 10:102. https:\/\/doi.org\/10.1038\/s41392-025-02168-0","journal-title":"Signal Transduct Target Ther"},{"key":"8418_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","volume":"74","author":"S Lazar","year":"2023","unstructured":"Lazar S, Kahlenberg JM (2023) Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med 74:339\u2013352. https:\/\/doi.org\/10.1146\/annurev-med-043021-032611","journal-title":"Annu Rev Med"},{"key":"8418_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/ard-2022-223035","volume":"82","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yao X et al (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82:351\u2013356. https:\/\/doi.org\/10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"8418_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-981-97-7288-9_10","volume":"1466","author":"Z Peng","year":"2024","unstructured":"Peng Z, Zhang H, Hu H (2024) The function of ubiquitination in T-cell development. Adv Exp Med Biol 1466:135\u2013159. https:\/\/doi.org\/10.1007\/978-981-97-7288-9_10","journal-title":"Adv Exp Med Biol"},{"key":"8418_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1146\/annurev-immunol-103019-085803","volume":"38","author":"M Ruterbusch","year":"2020","unstructured":"Ruterbusch M, Pruner KB, Shehata L et al (2020) In vivo CD4+ T cell differentiation and function: revisiting the Th1\/Th2 paradigm. Annu Rev Immunol 38:705\u2013725. https:\/\/doi.org\/10.1146\/annurev-immunol-103019-085803","journal-title":"Annu Rev Immunol"},{"key":"8418_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-0716-0266-9_8","volume":"2111","author":"W Yang","year":"2020","unstructured":"Yang W, Chen X, Hu H (2020) CD4+ T-cell differentiation in vitro. Methods Mol Biol 2111:91\u201399. https:\/\/doi.org\/10.1007\/978-1-0716-0266-9_8","journal-title":"Methods Mol Biol"},{"key":"8418_CR8","doi-asserted-by":"publisher","unstructured":"Qc TN, G D, Ph P. CD8+ (2025) T cell-based immunotherapy: promising frontier in human diseases. Biochemical Pharmacology, 237. https:\/\/doi.org\/10.1016\/j.bcp.2025.116909","DOI":"10.1016\/j.bcp.2025.116909"},{"key":"8418_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1683418","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Guo D, Zou IX et al (2025) CD3+CD4-CD8- T cells: a new potential therapeutic target in treating autoimmune diseases. Front Immunol 16:1683418. https:\/\/doi.org\/10.3389\/fimmu.2025.1683418","journal-title":"Front Immunol"},{"key":"8418_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2014.01.030","volume":"51","author":"A Alunno","year":"2014","unstructured":"Alunno A, Carubbi F, Bistoni O et al (2014) CD4(-)CD8(-) T-cells in primary Sj\u00f6gren\u2019s syndrome: association with the extent of glandular involvement. J Autoimmun 51:38\u201343. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.030","journal-title":"J Autoimmun"},{"key":"8418_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123459","volume":"10","author":"A Dutta","year":"2021","unstructured":"Dutta A, Venkataganesh H, Love PE (2021) New insights into epigenetic regulation of T cell differentiation. Cells 10:3459. https:\/\/doi.org\/10.3390\/cells10123459","journal-title":"Cells"},{"key":"8418_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103757","volume":"24","author":"MR Alam","year":"2025","unstructured":"Alam MR, Akinyemi AO, Wang J et al (2025) CD4+CD8+ double-positive T cells in immune disorders and cancer: prospects and hurdles in immunotherapy. Autoimmun Rev 24:103757. https:\/\/doi.org\/10.1016\/j.autrev.2025.103757","journal-title":"Autoimmun Rev"},{"key":"8418_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41577-018-0009-3","volume":"18","author":"P Golstein","year":"2018","unstructured":"Golstein P, Griffiths GM (2018) An early history of T cell-mediated cytotoxicity. Nat Rev Immunol 18:527\u2013535. https:\/\/doi.org\/10.1038\/s41577-018-0009-3","journal-title":"Nat Rev Immunol"},{"key":"8418_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271236","volume":"14","author":"A Malyshkina","year":"2023","unstructured":"Malyshkina A, Br\u00fcggemann A, Paschen A et al (2023) Cytotoxic CD4+ T cells in chronic viral infections and cancer. Front Immunol 14:1271236. https:\/\/doi.org\/10.3389\/fimmu.2023.1271236","journal-title":"Front Immunol"},{"key":"8418_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","volume":"247","author":"T Preglej","year":"2022","unstructured":"Preglej T, Ellmeier W (2022) CD4+ cytotoxic T cells \u2013 phenotype, function and transcriptional networks controlling their differentiation pathways. Immunol Lett 247:27\u201342. https:\/\/doi.org\/10.1016\/j.imlet.2022.05.001","journal-title":"Immunol Lett"},{"key":"8418_CR16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bj.2021.04.012","volume":"44","author":"AK Singh","year":"2021","unstructured":"Singh AK, Lin H-H (2021) The role of GPR56\/ADGRG1 in health and disease. Biomed J 44:534\u2013547. https:\/\/doi.org\/10.1016\/j.bj.2021.04.012","journal-title":"Biomed J"},{"key":"8418_CR17","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4049\/jimmunol.2101048","volume":"211","author":"C Liu","year":"2023","unstructured":"Liu C, Liu T, Hu Y et al (2023) G protein-coupled receptor 56 characterizes CTLs and reflects the progression of lung cancer patients. J Immunol 211:683\u2013692. https:\/\/doi.org\/10.4049\/jimmunol.2101048","journal-title":"J Immunol"},{"key":"8418_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/art.40038","volume":"69","author":"D Comte","year":"2017","unstructured":"Comte D, Karampetsou MP, Yoshida N et al (2017) SLAMF7 engagement restores defective effector CD8+ T cells activity in response to foreign antigens in systemic lupus erythematosus. Arthritis Rheumatol 69:1035\u20131044. https:\/\/doi.org\/10.1002\/art.40038","journal-title":"Arthritis Rheumatol"},{"key":"8418_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1654374","volume":"16","author":"J-E Sander","year":"2025","unstructured":"Sander J-E, Han I, Fickenscher L et al (2025) SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade. Front Immunol 16:1654374. https:\/\/doi.org\/10.3389\/fimmu.2025.1654374","journal-title":"Front Immunol"},{"key":"8418_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41418-024-01399-y","volume":"32","author":"H Lingel","year":"2025","unstructured":"Lingel H, Fischer L, Remstedt S et al (2025) SLAMF7 (CD319) on activated CD8+ T cells transduces environmental cues to initiate cytotoxic effector cell responses. Cell Death Differ 32:561\u2013572. https:\/\/doi.org\/10.1038\/s41418-024-01399-y","journal-title":"Cell Death Differ"},{"key":"8418_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/imm.70073","volume":"177","author":"Z Xiong","year":"2026","unstructured":"Xiong Z, Gao Y, He J et al (2026) GPR56 outperforms CD319 as a discriminative marker for CD4 + cytotoxic T lymphocytes and is elevated in primary Sj\u00f6gren\u2019s syndrome. Immunology 177:713\u2013724. https:\/\/doi.org\/10.1111\/imm.70073","journal-title":"Immunology"},{"key":"8418_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114738","volume":"157","author":"Z Xiong","year":"2025","unstructured":"Xiong Z, Zong Z, Bahabayi A et al (2025) Novel diagnostic biomarker and immune profiling of GPR56+ B cell subsets in systemic lupus erythematosus. Int Immunopharmacol 157:114738. https:\/\/doi.org\/10.1016\/j.intimp.2025.114738","journal-title":"Int Immunopharmacol"},{"key":"8418_CR23","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2249.2010.04116.x","volume":"160","author":"JR Kim","year":"2010","unstructured":"Kim JR, Mathew SO, Patel RK et al (2010) Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Clin Exp Immunol 160:348\u2013358. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04116.x","journal-title":"Clin Exp Immunol"},{"key":"8418_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271\u20131277. https:\/\/doi.org\/10.1002\/art.1780251101","journal-title":"Arthritis Rheum"},{"key":"8418_CR25","doi-asserted-by":"publisher","first-page":"9007","DOI":"10.1007\/s00432-023-04823-x","volume":"149","author":"J Lu","year":"2023","unstructured":"Lu J, Huang C, He R et al (2023) CD4-\/CD8- double-negative tumor-infiltrating lymphocytes expanded from solid tumor tissue suppress the proliferation of tumor cells in an MHC-independent way. J Cancer Res Clin Oncol 149:9007\u20139016. https:\/\/doi.org\/10.1007\/s00432-023-04823-x","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"8418_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40364-022-00360-w","volume":"10","author":"X Chen","year":"2022","unstructured":"Chen X, Wang D, Zhu X (2022) Application of double-negative T cells in haematological malignancies: recent progress and future directions. Biomark Res 10:11. https:\/\/doi.org\/10.1186\/s40364-022-00360-w","journal-title":"Biomark Res"},{"key":"8418_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000660","volume":"9","author":"S Yuan","year":"2022","unstructured":"Yuan S, Zeng Y, Li J et al (2022) Phenotypical changes and clinical significance of CD4+\/CD8+ T cells in SLE. Lupus Sci Med 9:e000660. https:\/\/doi.org\/10.1136\/lupus-2022-000660","journal-title":"Lupus Sci Med"},{"key":"8418_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.humimm.2016.06.007","volume":"77","author":"AS Shaltout","year":"2016","unstructured":"Shaltout AS, Sayed D, Badary MS et al (2016) Effect of IL6 and IL23 on double negative T cells and anti ds-DNA in systemic lupus erythematosus patients. Hum Immunol 77:937\u2013943. https:\/\/doi.org\/10.1016\/j.humimm.2016.06.007","journal-title":"Hum Immunol"},{"key":"8418_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41392-024-01800-9","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Yu Q, Li Z et al (2024) Protein neddylation and its role in health and diseases. Signal Transduct Target Ther 9:85. https:\/\/doi.org\/10.1038\/s41392-024-01800-9","journal-title":"Signal Transduct Target Ther"},{"key":"8418_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2022.100155","volume":"5","author":"JJBC van Beers","year":"2022","unstructured":"van Beers JJBC, Schreurs MWJ (2022) Anti-Sm antibodies in the classification criteria of systemic lupus erythematosus. J Transl Autoimmun 5:100155. https:\/\/doi.org\/10.1016\/j.jtauto.2022.100155","journal-title":"J Transl Autoimmun"},{"issue":"1","key":"8418_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/08916930400022715","volume":"38","author":"P Migliorini","year":"2005","unstructured":"Migliorini P, Baldini C, Rocchi V, Bombardieri S (2005) Anti-Sm and anti-RNP antibodies. Autoimmunity 38(1):47\u201354. https:\/\/doi.org\/10.1080\/08916930400022715","journal-title":"Autoimmunity"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08418-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-08418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:05:38Z","timestamp":1793423138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-08418-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8418"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-08418-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}